查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1889210

全球毛細管電泳市場：未來預測（至2032年）－按產品、類型、應用、最終用戶和地區分類的分析

Capillary Electrophoresis Market Forecasts to 2032 - Global Analysis By Product (Instruments, Consumables, and Software), Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球毛細管電泳市場價值將達到 3.977 億美元，到 2032 年將達到 6.5552 億美元，在預測期內的複合年成長率為 7.4%。

毛細管電泳是一種實驗室技術，它利用細小高壓毛細管中不同物質在電場作用下的電荷、尺寸和遷移速度差異，實現化學物質的分離。該技術能夠快速、準確、高解析度地分離複雜樣品。由於不同顆粒的移動速度不同，因此可以清晰地檢測和測量它們。毛細管電泳技術在藥物研發、生物技術研究、環境分析和醫學診斷檢測等領域有著廣泛的應用。

根據世界衛生組織（世衛組織）的數據，截至 2022 年底，全球估計有 3,900 萬人感染愛滋病毒，其中 3,750 萬人年齡在 15 歲或以上，150 萬人是 15 歲以下的兒童。

人們越來越關注個人化醫療

電泳 (CE) 能夠精確分離和分析生物分子，因此對於設計針對個別患者特徵的治療方法至關重要。基因組學和蛋白​​質組學的進步正在加速對高精度診斷工具的需求。製藥公司越來越依賴 CE 來支持其以標靶治療為重點的藥物開發平臺。 CE 能夠檢測微小的分子變異，這使其成為精準醫療的關鍵。隨著個人化醫療在全球的擴展，CE 已成為推動患者特異性解決方案創新發展的核心分析平台。

替代技術的存在

液相層析法和質譜等技術已廣泛應用，並常被某些應用領域所青睞。這些替代技術可提供與毛細管電泳 (CE) 相當的準確度，在某些情況下甚至具有更高的通量，這可能會限制 CE 在成本敏感型環境中的應用。如果現有技術能夠滿足實驗室的分析需求，他們可能不願意投資 CE 系統。結合多種分離技術的混合平台的出現進一步加劇了競爭壓力。因此，分析領域中成熟替代技術的強大影響力可能會阻礙 CE 的普及。

將CE與人工智慧(AI)和進階資料分析結合

人工智慧驅動的演算法增強了數據解讀能力，提高了準確性並減少了人為錯誤。先進的分析技術能夠即時監測複雜的分子交互作用，從而拓展了毛細管電泳在臨床和研究領域的效用。雲端基礎促進了對毛細管電泳數據的遠端訪問，支持跨區域的研究合作。這些創新有望簡化製藥和診斷檢查室的工作流程，並加快決策速度。隨著數位轉型推動醫療保健產業變革，毛細管電泳與人工智慧的結合必將帶來更高水準的效率和更深刻的洞察力。

保持設備間的標準化

不同系統間的表現差異會影響結果的可重複性。當設備缺乏統一標準時，實驗室往往難以進行校準和合規性檢查。這種不一致可能導致監管核准延遲，並降低人們對基於毛細管電泳（CE）診斷的信心。全球範圍內統一通訊協定和儀器規格仍然是一項持續的挑戰。如果沒有明確的標準化，毛細管電泳在製藥和臨床診斷等高度監管的行業中將面臨信譽受損的風險。

新冠疫情的影響：

新冠疫情擾亂了檢查室運作和供應鏈，暫時減緩了毛細管電泳（CE）技術的應用。然而，這場危機凸顯了快速、準確的分子檢測的重要性。 CE技術在病毒RNA和蛋白質分析相關研究中廣泛應用，幫助了疫情應對。遠端資料共用和數位化工作流程日益普及，加速了CE技術與雲端基礎平台的整合。疫情過後，市場預計將更加重視韌性、數位化敏捷性以及CE技術在感染疾病研究中的更廣泛應用。

預計在預測期內，設備細分市場將佔據最大的市場佔有率。

預計在預測期內，儀器設備領域將佔據最大的市場佔有率。儀器設備是毛細管電泳工作流程的核心，能夠實現生物分子的精確分離與檢測。其在製藥、生物技術和臨床應用中的多功能性推動了市場的穩定需求。儀器設計的不斷創新正在提升靈敏度、通量和自動化程度。實驗室正優先投資先進的儀器設備，以支持其長期的研究和診斷能力。

預計食品和環境檢查室領域在預測期內將實現最高的複合年成長率。

預計在預測期內，食品和環境檢查室領域將實現最高成長率。這主要歸因於人們對食品安全和環境污染日益成長的擔憂，從而推動了對先進分析工具的需求。化學分析（CE）在檢測污染物、添加劑和有害物質方面具有高靈敏度。世界各地的監管機構都在不斷提高標準，這促使人們更多地採用化學分析（CE）進行合規性檢測。化學分析（CE）能夠提供快速且準確的結果，使其在這些領域具有極高的價值。

佔比最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的醫療保健基礎設施和對生物技術研究的大力投入。美國和加拿大的製藥公司是毛細管電泳（CE）在藥物研發和診斷領域的主要應用者。完善的法規結構促進了分析技術的創新和快速應用。學術機構和研究中心也為毛細管電泳的廣泛應用做出了貢獻。

年複合成長率最高的地區：

預計亞太地區在預測期內將實現最高的複合年成長率，這主要得益於中國、印度和日本等國家醫療基礎設施的快速擴張，推動了相關技術的應用。政府為促進先進診斷技術和本地化生產而採取的措施也創造了有利條件。生物技術和製藥研發領域投資的增加正在加速CE的整合。個人化醫療和日益增強的食品安全意識也進一步推動了需求成長。

免費客製化服務：

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
  • 分析材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球毛細管電泳市場（依產品分類）

  • 裝置
    • 毛細管電泳系統
    • 高效能CE平台
  • 消耗品
    • 微血管
    • 緩衝溶液
    • 試劑
  • 軟體
    • 數據分析
    • 工作流程自動化

6. 全球毛細管電泳市場（按類型分類）

  • 毛細管區帶電泳（CZE）
  • 毛細管凝膠電泳（CGE）
  • 毛細管等電聚焦（CIEF）
  • 毛細管等速電泳 (CITP)
  • 膠束電泳層析法（MEKC）
  • 毛細管層析法（CEC）
  • 其他類型

7. 全球毛細管電泳市場（依應用領域分類）

  • 藥物發現與開發
  • 藥物動力學研究
  • 生物標記鑑定
  • 基因組學和蛋白​​質組學
  • 臨床診斷
  • 食品安全與環境檢測
  • 其他用途

8. 全球毛細管電泳市場（依最終用戶分類）

  • 製藥和生物技術公司
  • 學術和研究機構
  • 臨床檢查室
  • 食品與環境檢查室
  • 其他最終用戶

9. 全球毛細管電泳市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Agilent Technologies
  • Lumex Instruments
  • SCIEX
  • Harvard Bioscience
  • Bio-Rad Laboratories
  • Merck KGaA
  • Thermo Fisher Scientific
  • Promega Corporation
  • PerkinElmer
  • Analytik Jena
  • Shimadzu Corporation
  • Hitachi High-Tech Corporation
  • Beckman Coulter
  • Helena Laboratories
  • GE Healthcare
Product Code: SMRC32670

According to Stratistics MRC, the Global Capillary Electrophoresis Market is accounted for $397.70 million in 2025 and is expected to reach $655.52 million by 2032 growing at a CAGR of 7.4% during the forecast period. Capillary electrophoresis is a laboratory method that separates chemical substances within a thin, high-voltage capillary by exploiting differences in their charge, size, and movement under an electric field. This approach offers fast, accurate, and high-resolution separation of complex samples. As particles travel at different rates, they can be clearly detected and measured. The technique is commonly applied in drug development, biotech research, environmental analysis, and medical diagnostic testing.

According to World Health Organization (WHO) by the end of 2022, there were an estimated 39 million people living with HIV globally, of which 37.5 million were aged 15 and 1.5 million were children aged less than 15 years.

Market Dynamics:

Driver:

Increasing focus on personalized medicine

CE enables precise separation and analysis of biomolecules, which is critical for tailoring treatments to individual patient profiles. Advances in genomics and proteomics are fueling demand for highly accurate diagnostic tools. Pharmaceutical companies are increasingly relying on CE to support drug development pipelines focused on targeted therapies. The ability to detect subtle molecular variations makes CE indispensable in precision healthcare. As personalized medicine expands globally, CE is positioned as a core analytical platform driving innovation in patient-specific solutions.

Restraint:

Presence of alternative technologies

Techniques such as liquid chromatography and mass spectrometry are widely established and often preferred for certain applications. These alternatives offer comparable accuracy and sometimes greater throughput, limiting CE's adoption in cost-sensitive environments. Laboratories may hesitate to invest in CE systems when existing technologies already meet their analytical needs. The availability of hybrid platforms that combine multiple separation methods further intensifies competitive pressure. As a result, CE adoption is sometimes restrained by the strong presence of established alternatives in the analytical landscape.

Opportunity:

Integration of CE with artificial intelligence (AI) and advanced data analytics

AI-driven algorithms can enhance data interpretation, improving accuracy and reducing manual errors. Advanced analytics enable real-time monitoring of complex molecular interactions, expanding CE's utility in clinical and research settings. Cloud-based platforms are facilitating remote access to CE data, supporting collaborative research across geographies. These innovations are expected to streamline workflows and accelerate decision-making in pharmaceutical and diagnostic laboratories. As digital transformation reshapes healthcare, CE combined with AI is poised to unlock new levels of efficiency and insight.

Threat:

Maintaining standardization across instruments

Variability in performance between different systems can hinder reproducibility of results. Laboratories often struggle with calibration and compliance when instruments lack uniform standards. This inconsistency can slow regulatory approvals and limit confidence in CE-based diagnostics. Global harmonization of protocols and instrument specifications remains an ongoing challenge. Without clear standardization, CE risks losing credibility in highly regulated industries such as pharmaceuticals and clinical diagnostics.

Covid-19 Impact:

The COVID-19 pandemic disrupted laboratory operations and supply chains, temporarily slowing CE adoption. However, the crisis also highlighted the importance of rapid and accurate molecular testing. CE gained traction in research related to viral RNA and protein analysis, supporting pandemic response efforts. Remote data sharing and digital workflows became more common, accelerating the integration of CE with cloud-based platforms. Post-pandemic, the market is expected to emphasize resilience, digital agility, and expanded use of CE in infectious disease research.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is expected to account for the largest market share during the forecast period. Instruments form the backbone of CE workflows, enabling precise separation and detection of biomolecules. Their versatility across pharmaceutical, biotechnology, and clinical applications drives consistent demand. Continuous innovation in instrument design is improving sensitivity, throughput, and automation. Laboratories prefer investing in advanced instruments to support long-term research and diagnostic capabilities.

The food & environmental testing labs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the food & environmental testing labs segment is predicted to witness the highest growth rate, due to rising concerns about food safety and environmental contamination are driving demand for advanced analytical tools. CE offers high sensitivity in detecting contaminants, additives, and pollutants. Regulatory agencies worldwide are tightening standards, encouraging laboratories to adopt CE for compliance testing. The ability to deliver rapid and accurate results makes CE highly valuable in these sectors.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the region benefits from advanced healthcare infrastructure and strong investment in biotechnology research. Pharmaceutical companies in the U.S. and Canada are leading adopters of CE for drug development and diagnostics. Supportive regulatory frameworks encourage innovation and faster adoption of analytical technologies. Academic institutions and research centers further contribute to widespread CE utilization.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapidly expanding healthcare infrastructure in countries like China, India, and Japan is fueling adoption. Government initiatives promoting advanced diagnostics and local manufacturing are creating favorable conditions. Rising investments in biotechnology and pharmaceutical research are accelerating CE integration. Growing awareness of personalized medicine and food safety is further driving demand.

Key players in the market

Some of the key players in Capillary Electrophoresis Market include Agilent Technologies, Lumex Instruments, SCIEX, Harvard Bioscience, Bio-Rad Laboratories, Merck KGaA, Thermo Fisher Scientific, Promega Corporation, PerkinElmer, Analytik Jena, Shimadzu, Hitachi High-Tech, Beckman Coulter, Helena Laboratories, and GE Healthcare.

Key Developments:

In November 2025, GE HealthCare announced it has entered into an agreement to acquire Intelerad, a leading medical imaging software provider for the healthcare industry, for a purchase price of $2.3 billion paid in cash. This acquisition demonstrates GE HealthCare's continued commitment to cloud-enabled and AI-powered solutions across care settings and furthers the company's aim to triple its offerings of cloud-enabled products.

In September 2025, Agilent Technologies Inc. announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications. The Agilent Altura Ultra Inert HPLC Columns set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical companies need for the most demanding applications, including peptide GLP-1 and oligonucleotide therapeutic development and quality control.

Products Covered:

  • Instruments
  • Consumables
  • Software

Types Covered:

  • Capillary Zone Electrophoresis (CZE)
  • Capillary Gel Electrophoresis (CGE)
  • Capillary Isoelectric Focusing (CIEF)
  • Capillary Isotachophoresis (CITP)
  • Micellar Electrokinetic Chromatography (MEKC)
  • Capillary Electrochromatography (CEC)
  • Other Types

Applications Covered:

  • Drug Discovery & Development
  • Pharmacokinetics Studies
  • Biomarker Identification
  • Genomics & Proteomics
  • Clinical Diagnostics
  • Food Safety & Environmental Testing
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Clinical Laboratories
  • Food & Environmental Testing Labs
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Capillary Electrophoresis Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 Capillary electrophoresis systems
    • 5.2.2 High-performance CE platforms
  • 5.3 Consumables
    • 5.3.1 Capillaries
    • 5.3.2 Buffers
    • 5.3.3 Reagents
  • 5.4 Software
    • 5.4.1 Data Analysis
    • 5.4.2 Workflow Automation

6 Global Capillary Electrophoresis Market, By Type

  • 6.1 Introduction
  • 6.2 Capillary Zone Electrophoresis (CZE)
  • 6.3 Capillary Gel Electrophoresis (CGE)
  • 6.4 Capillary Isoelectric Focusing (CIEF)
  • 6.5 Capillary Isotachophoresis (CITP)
  • 6.6 Micellar Electrokinetic Chromatography (MEKC)
  • 6.7 Capillary Electrochromatography (CEC)
  • 6.8 Other Types

7 Global Capillary Electrophoresis Market, By Application

  • 7.1 Introduction
  • 7.2 Drug Discovery & Development
  • 7.3 Pharmacokinetics Studies
  • 7.4 Biomarker Identification
  • 7.5 Genomics & Proteomics
  • 7.6 Clinical Diagnostics
  • 7.7 Food Safety & Environmental Testing
  • 7.8 Other Applications

8 Global Capillary Electrophoresis Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical & Biotechnology Companies
  • 8.3 Academic & Research Institutes
  • 8.4 Clinical Laboratories
  • 8.5 Food & Environmental Testing Labs
  • 8.6 Other End Users

9 Global Capillary Electrophoresis Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies
  • 11.2 Lumex Instruments
  • 11.3 SCIEX
  • 11.4 Harvard Bioscience
  • 11.5 Bio-Rad Laboratories
  • 11.6 Merck KGaA
  • 11.7 Thermo Fisher Scientific
  • 11.8 Promega Corporation
  • 11.9 PerkinElmer
  • 11.10 Analytik Jena
  • 11.11 Shimadzu Corporation
  • 11.12 Hitachi High-Tech Corporation
  • 11.13 Beckman Coulter
  • 11.14 Helena Laboratories
  • 11.15 GE Healthcare

List of Tables

  • Table 1 Global Capillary Electrophoresis Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Capillary Electrophoresis Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Capillary Electrophoresis Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 4 Global Capillary Electrophoresis Market Outlook, By Capillary electrophoresis systems (2024-2032) ($MN)
  • Table 5 Global Capillary Electrophoresis Market Outlook, By High-performance CE platforms (2024-2032) ($MN)
  • Table 6 Global Capillary Electrophoresis Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 7 Global Capillary Electrophoresis Market Outlook, By Capillaries (2024-2032) ($MN)
  • Table 8 Global Capillary Electrophoresis Market Outlook, By Buffers (2024-2032) ($MN)
  • Table 9 Global Capillary Electrophoresis Market Outlook, By Reagents (2024-2032) ($MN)
  • Table 10 Global Capillary Electrophoresis Market Outlook, By Software (2024-2032) ($MN)
  • Table 11 Global Capillary Electrophoresis Market Outlook, By Data Analysis (2024-2032) ($MN)
  • Table 12 Global Capillary Electrophoresis Market Outlook, By Workflow Automation (2024-2032) ($MN)
  • Table 13 Global Capillary Electrophoresis Market Outlook, By Type (2024-2032) ($MN)
  • Table 14 Global Capillary Electrophoresis Market Outlook, By Capillary Zone Electrophoresis (CZE) (2024-2032) ($MN)
  • Table 15 Global Capillary Electrophoresis Market Outlook, By Capillary Gel Electrophoresis (CGE) (2024-2032) ($MN)
  • Table 16 Global Capillary Electrophoresis Market Outlook, By Capillary Isoelectric Focusing (CIEF) (2024-2032) ($MN)
  • Table 17 Global Capillary Electrophoresis Market Outlook, By Capillary Isotachophoresis (CITP) (2024-2032) ($MN)
  • Table 18 Global Capillary Electrophoresis Market Outlook, By Micellar Electrokinetic Chromatography (MEKC) (2024-2032) ($MN)
  • Table 19 Global Capillary Electrophoresis Market Outlook, By Capillary Electrochromatography (CEC) (2024-2032) ($MN)
  • Table 20 Global Capillary Electrophoresis Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 21 Global Capillary Electrophoresis Market Outlook, By Application (2024-2032) ($MN)
  • Table 22 Global Capillary Electrophoresis Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
  • Table 23 Global Capillary Electrophoresis Market Outlook, By Pharmacokinetics Studies (2024-2032) ($MN)
  • Table 24 Global Capillary Electrophoresis Market Outlook, By Biomarker Identification (2024-2032) ($MN)
  • Table 25 Global Capillary Electrophoresis Market Outlook, By Genomics & Proteomics (2024-2032) ($MN)
  • Table 26 Global Capillary Electrophoresis Market Outlook, By Clinical Diagnostics (2024-2032) ($MN)
  • Table 27 Global Capillary Electrophoresis Market Outlook, By Food Safety & Environmental Testing (2024-2032) ($MN)
  • Table 28 Global Capillary Electrophoresis Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 29 Global Capillary Electrophoresis Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Capillary Electrophoresis Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 31 Global Capillary Electrophoresis Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 32 Global Capillary Electrophoresis Market Outlook, By Clinical Laboratories (2024-2032) ($MN)
  • Table 33 Global Capillary Electrophoresis Market Outlook, By Food & Environmental Testing Labs (2024-2032) ($MN)
  • Table 34 Global Capillary Electrophoresis Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.